Suzhen Ran

Mrs. Suzhen Ran


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 January 2025 in Foods
Verified
Journal Article
Open access
PDF file
SLShang Lv
Shang Lv
BHBin Hu
Bin Hu
SRSuzhen Ran
Suzhen Ran
MZMin Zhang
Min Zhang
Changfeng ChiChangfeng Chi
Changfeng Chi
Bin WangBin Wang
Bin Wang
Hijiki (Hizikia fusiformis) is a seaweed native to warm-temperate and subtropical regions that has a high edible value and economic value, with a production of about 2 × 105 tons/year. Current research has clearly shown that the pharmacological activities of active ingredients from hijiki have covered a broad spectrum of areas, including antioxidant, hypoglycemic, antiviral, anticoagulant, anti-inflammatory, intestinal flora modulation, anti-aging, antineoplastic and antibacterial, and anti-Alzheimer’s disease areas. However, no studies have reported on the production of antioxidant peptides from hijiki proteins. The objectives of this study were to optimize the preparation process and explore the cytoprotective function and mechanisms of antioxidant peptides from hijiki protein. The results indicated that papain is more suitable for hydrolyzing hijiki protein than pepsin, trypsin, alkaline protease, and neutral protease. Under the optimized parameters of an enzyme dosage of 3%, a material–liquid ratio of 1:30, and an enzyme digestion time of 5 h, hijiki hydrolysate with a high radical scavenging activity was generated. Using ultrafiltration and serial chromatographic methods, ten antioxidant oligopeptides were purified from the papain-prepared hydrolysate and identified as DGPD, TIPEE, TYRPG, YTPAP, MPW, YPSKPT, YGALT, YTLLQ, FGYGP, and FGYPA with molecular weights of 402.35, 587.61, 592.64, 547.60, 532.53, 691.77, 523.57, 636.73, 539.58, and 553.60 Da, respectively. Among them, tripeptide MPW could regulate the Keap1/Nrf2 pathway to significantly ameliorate H2O2-induced oxidative damage of A549 cells by increasing cell viability and antioxidant enzyme (SOD, CAT, and GSH-Px) activity, decreasing ROS and MDA levels, and reducing the apoptosis rate. Molecular docking experiments show that HFP5 (MPW) exerts its inhibitory effect mainly through hydrogen bonds and hydrophobic interactions with the Kelch domain of the Keap1 protein, eventually facilitating the translocation of Nrf2 to the nucleus. Therefore, antioxidant peptides from hijiki can be applied to develop algae-derived health foods for treating diseases associated with oxidative stress.

1 February 2025 in Marine Drugs
Verified
Journal Article
Open access
PDF file
YWYu-Mei Wang
Yu-Mei Wang
MGMing-Xue Ge
Ming-Xue Ge
SRSuzhen Ran
Suzhen Ran
XPXin Pan
Xin Pan
Changfeng ChiChangfeng Chi
Changfeng Chi
Bin WangBin Wang
Bin Wang
In this work, the hypolipidemic and antioxidative capacity of FSGLR (S7) and GIEWA (S10) from miiuy croaker swim bladders was explored systematically in an oleic acid (OA)-induced nonalcoholic fatty liver disease (NAFLD) model of HepG2 cells. Moreover, the hypolipidemic activity of S7 and S10 and their antioxidative abilities were preliminarily investigated in combination with molecular docking technology. The results indicated that S7 and S10 could decrease the amount of lipid accumulation and the content of triglycerides (TG) and total cholesterol (TC) in the OA-induced NAFLD cell model in a dose-dependent manner. In addition, S7 and S10 exhibited better bile salt binding, pancreatic lipase (PL) inhibition, and cholesterol esterase (CE) inhibition capacities. The hypolipidemic mechanisms of S7 and S10 were connected with the downregulation of the mRNA expression levels of adipogenic factors, including sterol-regulatory element-binding protein-1c (SREBP-1c), acetyl-CoA carboxylase (ACC), sterol-regulatory element-binding protein (SREBP)-2, hydroxymethylglutaryl-CoA reductase (HMGR), and fatty acid synthase (FAS) (p < 0.01), and the upregulation of the mRNA expression of β-oxidation-related factors, including carnitine palmitoyltransferase 1 (CPT-1), acyl-CoA oxidase 1 (ACOX-1), and peroxisome proliferator-activated receptor α (PPARα). Moreover, FSGLR (S7) and GIEWA (S10) could significantly protect HepG2 cells against OA-induced oxidative damage, and their antioxidant mechanisms were related to the increased activity of intracellular antioxidant proteases (superoxide dismutase, SOD; glutathione peroxidase, GSH-PX; catalase, CAT) to remove excess reactive oxygen species (ROS) and decrease the production of malondialdehyde (MDA). The presented findings indicate that the hypolipidemic and antioxidant functions and mechanisms of S7 and S10 could make them potential hypolipidemic and antioxidant candidates for the treatment of NAFLD.

24 February 2025 in Animals
Verified
Journal Article
Open access
PDF file
HLHaolin Li
Haolin Li
SRSuzhen Ran
Suzhen Ran
XWXiaoyu Wang
Xiaoyu Wang
BSBin shen Shen
Bin shen Shen
JZJianshe Zhang
Jianshe Zhang
Superoxide dismutases (SODs) are critical antioxidant enzymes that protect organisms by catalyzing the dismutation of superoxide radicals into molecular oxygen (O2) and hydrogen peroxide (H2O2). In this study, we cloned the full-length cDNA of two SODs (BsCu/Zn-SOD and BsMn-SOD) from the Chinese black sleeper. The cDNA of BsCu/Zn-SOD consists of 465 nucleotides encoding 154 amino acids, while the BsMn-SOD comprises 678 nucleotides encoding 225 amino acids. The PCR results indicated that in normal tissues, the highest expression of BsCu/Zn-SOD (1.02-fold) was primarily observed in muscle, whereas the highest expression of BsMn-SOD (6.42-fold) was noted in skin. Following treatment with Vibrio parahaemolyticus, the highest expression of BsCu/Zn-SOD (3.67-fold) was detected in the spleen, while BsMn-SOD (3.36-fold) presented the highest expression in the blood. After poly(I:C) treatment, the highest expression of BsCu/Zn-SOD (2.92-fold) was found in the blood, with BsMn-SOD (2.37-fold) showing the highest expression in the spleen. Following Cd2+ treatment, the highest expression of BsCu/Zn-SOD (3.36-fold) was recorded in the liver at the 1/2 96 h LC50 concentration, and in the spleen at both the 1/4 96 h LC50 (2.50-fold) and 1/8 96 h LC50 concentrations. In contrast, BsMn-SOD presented the highest expression (2.60-fold) in the liver across all three concentrations. These findings suggest that both BsCu/Zn-SOD and BsMn-SOD play vital roles in the innate immune response to environmental challenges, laying the foundation for further exploration of antioxidant mechanisms.